Some studies have indicated that total α-synuclein levels are reduced in the CSF of patients with PD compared to the values of healthy controls and non-parkinsonian conditions such as Alzheimer’s disease [35,36]. This evidence concerns the gene SNCA and early-onset autosomal dominant Alzheimer disease.